JP2004502025A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502025A5 JP2004502025A5 JP2002506748A JP2002506748A JP2004502025A5 JP 2004502025 A5 JP2004502025 A5 JP 2004502025A5 JP 2002506748 A JP2002506748 A JP 2002506748A JP 2002506748 A JP2002506748 A JP 2002506748A JP 2004502025 A5 JP2004502025 A5 JP 2004502025A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated compound
- acetylneuraminic acid
- formula
- linkage
- embedded image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 11
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 8
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 5
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 5
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 4
- 229940060155 neuac Drugs 0.000 description 4
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 4
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 3
- 125000005630 sialyl group Chemical group 0.000 description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/018219 WO2002002127A1 (en) | 2000-07-03 | 2000-07-03 | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007096954A Division JP2007191490A (ja) | 2007-04-02 | 2007-04-02 | 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004502025A JP2004502025A (ja) | 2004-01-22 |
| JP2004502025A5 true JP2004502025A5 (enExample) | 2006-01-05 |
Family
ID=21741553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002506748A Pending JP2004502025A (ja) | 2000-07-03 | 2000-07-03 | 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1307207A4 (enExample) |
| JP (1) | JP2004502025A (enExample) |
| KR (1) | KR100666238B1 (enExample) |
| CN (1) | CN1291723C (enExample) |
| AU (2) | AU6065200A (enExample) |
| WO (1) | WO2002002127A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5331293B2 (ja) * | 2006-04-28 | 2013-10-30 | 公益財団法人野口研究所 | 多様性を表現するオリゴ糖またはその誘導体 |
| AU2008361352B2 (en) * | 2008-09-07 | 2013-05-09 | Glyconex Inc. | Anti-extended Type I glycosphingolipid antibody, derivatives thereof and use |
| CN104655859B (zh) * | 2013-11-21 | 2017-10-03 | 苏州中赢医疗科技有限公司 | 乳腺癌的诊断标志物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083929A (en) * | 1991-05-06 | 2000-07-04 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| WO1992019634A1 (en) * | 1991-05-06 | 1992-11-12 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
-
2000
- 2000-07-03 AU AU6065200A patent/AU6065200A/xx active Pending
- 2000-07-03 AU AU2000260652A patent/AU2000260652B2/en not_active Expired
- 2000-07-03 EP EP00946971A patent/EP1307207A4/en not_active Withdrawn
- 2000-07-03 JP JP2002506748A patent/JP2004502025A/ja active Pending
- 2000-07-03 CN CNB008197881A patent/CN1291723C/zh not_active Expired - Lifetime
- 2000-07-03 WO PCT/US2000/018219 patent/WO2002002127A1/en not_active Ceased
- 2000-07-03 KR KR1020037000034A patent/KR100666238B1/ko not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5580858A (en) | Immunosuppressive and tolerogenic modified Lewisx compounds | |
| EP0589933B1 (en) | Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides | |
| Easton et al. | Pregnancy-associated changes in the glycosylation of Tamm-Horsfall glycoprotein: expression of sialyl lewisx sequences on core 2 typeo-glycans derived from uromodulin | |
| US8158763B2 (en) | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these | |
| CA2418815A1 (en) | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | |
| UCHIKAWA et al. | Structural studies on teichoic acids in cell walls of several serotypes of Listeria monocytogenes | |
| US6013779A (en) | Process for preparation of glycosides of tumor-associated carbohydrate antigens | |
| CA2110797C (en) | Modified sialyl lewis x compounds | |
| Campagnari et al. | Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis | |
| US20050038184A1 (en) | Saccharide residue-functional corganopolysiloxanes and method for the preparation thereof | |
| EP0344955A3 (en) | Novel long-chain glycolipid structure | |
| ATE356845T1 (de) | Saccharide-enthaltende funktionelle organopolycarbosiloxane und verfahren zu deren herstellung | |
| Neethling et al. | The reducing end of αGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera | |
| JP2004502025A5 (enExample) | ||
| Abronina et al. | The use of silyl groups in the synthesis of arabinofuranosides | |
| JP2908558B2 (ja) | 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法 | |
| CA2110582C (en) | Modified sialyl lewis a compounds | |
| CN1293679A (zh) | 新的五糖及其制备方法和含有它们的药物组合物 | |
| US6060597A (en) | Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases | |
| JPH04502010A (ja) | グリコサミノシルトランスフェラーゼvの阻害剤 | |
| CN1317053A (zh) | 生产唾液酸化寡糖的方法 | |
| Matsumoto et al. | Carbohydrates of influenza virus hemagglutinin: structures of the whole neutral sugar chains | |
| JPH0816118B2 (ja) | 抗ウイルス剤 | |
| JPH1025305A (ja) | 分岐シクロデキストリンおよびその製造方法 | |
| WO1992022564A1 (en) | Immunosuppressive and tolerogenic modified lewisx and lewisa compounds |